The Latest in Diabetes

‘Modest’ benefit for post-MI T2D glucose monitoring

October 20, 2020

Diabetes

COVID-19 antibody response not reduced with diabetes

October 20, 2020

Diabetic neuropathic pain linked to brain bioenergic anomalies

October 19, 2020

Diabetes

Recall widens for diabetes drug metformin

October 16, 2020

Diabetes

Substance in tears could be used for diabetes monitoring

October 16, 2020

Diabetes

Entresto halves renal events in preserved EF heart failure patients

October 15, 2020

Diabetes

T2D treatments create tension between glycemic and cardiovascular goals

October 12, 2020

Diabetes

Empagliflozin cut PA pressures in heart failure patients

October 12, 2020

Diabetes

EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartan

October 6, 2020

Diabetes

PPIs associated with diabetes risk, but questions remain

October 6, 2020

Diabetes

Time to screen for liver disease in type 2 diabetes?

October 5, 2020

Diabetes

Dapagliflozin’s CKD performance sends heart failure messages

October 5, 2020

Diabetes

British protocol allows insulin-treated pilots to fly safely

October 1, 2020

Diabetes

AHA scientific statement highlights cardiorenal benefit of new diabetes drugs

October 1, 2020

Diabetes

Geriatric patients: My three rules for them

October 1, 2020